Michel W Wouters
Overview
Explore the profile of Michel W Wouters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huis In t Veld E, Boere T, Zuur C, Wouters M, van Akkooi A, Haanen J, et al.
Ann Surg Oncol
. 2023 Mar;
30(8):5017-5026.
PMID: 36991168
Background: Although cutaneous squamous cell carcinoma (cSCC) is common, lymph node metastases are relatively rare and are usually treated with lymph node dissection (LND). The aim of this study was...
2.
Reijers I, Rao D, Versluis J, Menzies A, Dimitriadis P, Wouters M, et al.
J Exp Med
. 2023 Mar;
220(5).
PMID: 36920329
Neoadjuvant ipilimumab + nivolumab has demonstrated high pathologic response rates in stage III melanoma. Patients with low intra-tumoral interferon-γ (IFN-γ) signatures are less likely to benefit. We show that domatinostat...
3.
Reijers I, Menzies A, van Akkooi A, Versluis J, van den Heuvel N, Saw R, et al.
Nat Med
. 2022 Jun;
28(6):1178-1188.
PMID: 35661157
Neoadjuvant ipilimumab and nivolumab induces high pathologic response rates (pRRs) in clinical stage III nodal melanoma, and pathologic response is strongly associated with prolonged relapse-free survival (RFS). The PRADO extension...
4.
Reijers I, Rawson R, Colebatch A, Rozeman E, Menzies A, van Akkooi A, et al.
JAMA Surg
. 2022 Feb;
157(4):335-342.
PMID: 35138335
Importance: Neoadjuvant checkpoint inhibition in patients with high-risk stage III melanoma shows high pathologic response rates associated with a durable relapse-free survival. Whether a therapeutic lymph node dissection (TLND) can...
5.
Versluis J, Reijers I, Rozeman E, Menzies A, van Akkooi A, Wouters M, et al.
Eur J Cancer
. 2021 Mar;
148:51-57.
PMID: 33735809
Background: Patients with synchronous clinical stage III melanoma can present with primary melanoma lesions, locally recurrent melanoma or in-transit metastases. Neoadjuvant ipilimumab plus nivolumab induces high pathologic response rates and...
6.
Stahlie E, van der Hiel B, Stokkel M, Schrage Y, van Houdt W, Wouters M, et al.
J Surg Oncol
. 2020 Aug;
122(7):1328-1336.
PMID: 32783266
Background: The role of surveillance imaging in high-risk stage III melanoma patients after complete surgical resection remains controversial, and with the advent of adjuvant therapy, it may also be expanded....
7.
Beck N, van Bommel A, Eddes E, van Leersum N, Tollenaar R, Wouters M
Ann Surg
. 2020 Jan;
271(4):627-631.
PMID: 31972639
No abstract available.
8.
Huijts D, Guicherit O, Dekker J, van Groningen J, van Bodegom-Vos L, Bastiaannet E, et al.
J Natl Compr Canc Netw
. 2019 Jul;
17(7):821-828.
PMID: 31319385
Background: Previous studies showing higher mortality after elective surgery performed on a Friday were based on administrative data, known for insufficient case-mix adjustment. The goal of this study was to...
9.
Huijts D, van Groningen J, Guicherit O, Dekker J, van Bodegom-Vos L, Bastiaannet E, et al.
J Natl Compr Canc Netw
. 2018 Jun;
16(6):735-741.
PMID: 29891525
It is unclear whether emergency weekend colon and rectal cancer surgery are associated with worse outcomes (ie, weekend effect) because previous studies mostly used administrative data, which may insufficiently adjust...
10.
Kilsdonk M, Siesling S, van Dijk B, Wouters M, van Harten W
PLoS One
. 2018 Apr;
13(4):e0195673.
PMID: 29649250
Background: To improve quality of care, centralisation of cancer services in high-volume centres has been stimulated. Studies linking specialisation and high (surgical) volumes to better outcomes already appeared in the...